Hypoxia-specific gene expression for ischemic disease gene therapy
- 1 July 2009
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 61 (7-8), 614-622
- https://doi.org/10.1016/j.addr.2009.04.009
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Delivery of hypoxia-inducible VEGF gene to rat islets using polyethylenimineJournal of Drug Targeting, 2009
- The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenograftsBiochemical and Biophysical Research Communications, 2007
- Multiple Factors Affecting Cellular Redox Status and Energy Metabolism Modulate Hypoxia-Inducible Factor Prolyl Hydroxylase Activity In Vivo and In VitroMolecular and Cellular Biology, 2007
- Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: Prolyl hydroxylases tune the biological normoxic set pointFree Radical Biology & Medicine, 2006
- Combined Angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemiaMolecular Therapy, 2006
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004
- HIF-1α-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathwayBiochemical and Biophysical Research Communications, 2002
- Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylationThe EMBO Journal, 2001
- Common Proteins Bind mRNAs Encoding Erythropoietin, Tyrosine Hydroxylase, and Vascular Endothelial Growth FactorBiochemical and Biophysical Research Communications, 1998
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985